| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.092 | 0.8 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.046 | 0.8 |